Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...
13d
Medical Device Network on MSNCardiac Dimensions snags $53m for mitral valve deviceCardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...
Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.
Cardiac Dimensions has about 70 employees globally: 40 in Kirkland, 10 throughout the United States, and 20 in Europe.
KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions ®, a leader in minimally invasive treatments for heart failure and functional mitral regurgitation (FMR), today announced the close of an ...
People who regularly engage in significant amounts of exercise, as endurance athletes do, may develop enlarged hearts. While ...
Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment ...
To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System “Cardiac Dimensions is uniquely positioned to provide a safe ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results